NCT00056433View on ClinicalTrials.gov

Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

March 10, 2003

Primary Completion Date

December 27, 2006

Study Completion Date

December 27, 2006

Conditions
Sickle Cell Anemia
Interventions
DRUG

Hydroxyurea

DRUG

L-Arginine

DRUG

Sildenafil

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00056433 - Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia | Biotech Hunter | Biotech Hunter